Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for UROKINASE
- A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)
- PLEURAL IRRIGATION WITH NORMAL SALINE VERSUS INTRAPLEURAL FIBRINOLYTIC IN PLEURAL INFECTION
- Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
- 1-Year Follow-up of OPTIMA-5
- Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
- Efficacy and Safety of an Early Phase Single-bolus r-SAK for Acute Myocardial Infarction
- COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES
- SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
- Effects of Edoxaban on Platelet Aggregation
- Efficacy of an Early Phase Single Bolus r-SAK for Acute Myocardial Infarction: a Multi-center Randomized Clinical Trial
- Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke
- Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
- suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19
- Thrombolysis of Urokinase for Minor Stroke
- Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
- suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
- Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
- A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions
- suPAR to Guide Antibiotics in Emergency Department
- Efficacy of Fibrinolytic Agents in Complicated Pleural Effusion
- Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
- Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
- uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105
- Evaluating Different Modalities for Pleural Adhesiolysis at Assuit University Hospital
- A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein
- Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) Occlusions
- Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C
- Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
- uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
- uPAR-PET/MRI in Glioblastoma Multiforme
- Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar
- Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset
- The Effect of Tranexamic Acid on Uterine Blood Flow After Vaginal Delivery
- A Crossover Pilot Study of the Effect of Amiloride on Proteinuria
- Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
- Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
- Comparison of Intrapleural Urokinase and Video-Assisted Thorascopic Surgery in the Treatment of Parapneumonic Pleural Effusion in Children
- Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
- Amiloride for Resistant Hypertension
- Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase
- Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis
- Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
- The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers
- Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
- Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA
- Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia
- Local Thrombolytics Before Thrombectomy in STEMI
- Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema
- 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients
- Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
- Intrapleural Urokinase for Retained Hemothorax
- The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
- Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
- Urokinase Therapy in Patients With Diabetic Foot Syndrome
- 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
- Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood
- Urokinase Therapy in Diabetic Foot Syndrome
- Diurnal Variation of Plasminogen Activator Inhibitor-1
- Dornase Alfa and Urokinase for Kids With Pleural Empyema
- Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
- Phase I Study of Aprotinin in Advanced Breast Cancer
- Urokinase Versus Primary Video-Assisted Thorascopic Surgery for Empyema
- Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies
- Treatment for Blood Clots in the Veins of the Legs
Clinical trials list
click for details